330
Participants
Start Date
November 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Pardaprunox
12-42 mg
pramipexole
1.5-4.5 mg
Placebo Comparator
Placebo
419, Birmingham
413, Oceanside
408, Oxnard
422, New Haven
403, Boca Raton
411, Sarasota
421, Augusta
410, Fort Wayne
417, Lexington
405, Boston
420, Boston
415, Grand Rapids
416, Golden Valley
406, Minneapolis
418, Albany
424, Charlotte
412, Raleigh
303, Bedford Park
304, Cheltenham
301, Concord
302, Westmead
315, Kralove
313, Olomouc
310, Ostrava
314, Ostrava
312, Pardubice
311, Pilsen
320, Tallinn
321, Tartu
323, Aix-en-Provence
324, Toulon
325, Toulouse
332, Bochum
331, Göttingen
329, Heidelberg
327, Homburg
330, Leipzig
328, Lübeck
326, Wiesbaden
338, Bangalore
339, Hyderabad
337, Kerala
336, Mumbai
340, Mumbai
347, Arcugnano (VI)
348, Grosseto GR
346, Lido Di Camaiore (LU)
344, Pescara
343, Roma
345, Roma
428, Kaunas
427, Vilnius
429, Vilnius
355, Kelantan
357, Kuala Lumpur
356, Pulau Pinang
361, 's-Hertogenbosch
364, Eindhoven
363, Emmen
362, Groningen
360, RM Groningen
373, Gdansk
371, Kalisz
369, Katowice
374, Katowice
365, Krakow
368, Leszno
366, Lublin
370, Mosina
367, Torun
376, Coimbra
375, Lisbon
377, Cape Town
378, Cape Town
380, Gauteng
381, Pretoria
379, Sandton
383, Barcelona
384, Colmenar Viejo
382, Donostia / San Sebastian
388, Hualien City
387, Kaohsiung City
389, Kaohsiung Hsien
386, Kweishan
385, Taipei
391, Bangkok
393, Bangkok
394, Ubonratchathani Province
396, Blackpool
Solvay Pharmaceuticals
INDUSTRY